Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
Clinical trial NCT00442325 · COMPLETED
Trial details
- NCT number
- NCT00442325
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 595
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.